PBAX

Phoenix Biotech Aquisition (PBAX)

Phoenix Biotech Aquisition Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PBAX

일자	시간	출처	헤드라인	심볼	기업
2024/02/15	06:48	Business Wire	Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/06/07	19:05	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/06/05	22:27	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/06/05	21:00	Business Wire	CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/05/13	05:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/03/24	19:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/02/15	05:46	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/02/15	03:52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/02/14	20:11	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2023/01/25	21:25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/12/21	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/12/08	06:08	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/12/08	06:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/11/21	22:39	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/11/11	06:07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/11/05	05:07	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/10/31	22:29	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/10/31	22:27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/08/12	05:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/05/14	05:12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/03/25	05:13	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/02/12	06:51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/02/09	06:06	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2022/02/03	22:22	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2021/11/23	06:15	GlobeNewswire Inc.	Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2021/10/09	05:00	GlobeNewswire Inc.	Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation
2021/10/06	06:19	GlobeNewswire Inc.	Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public Offering	NASDAQ:PBAX	Phoenix Biotech Aquisition Corporation